Real-world safety profile of live attenuated Japanese encephalitis vaccine before and after the vaccine administration law [0.03%]
Chao Zhang,Yan Liu,Xiaofu Luo et al.
Chao Zhang et al.
Purpose: Live attenuated Japanese encephalitis vaccine (JEV-L) was included in the Expanded program on immunization on Immunization (EPI) in 2008 and has had a satisfactory effectiveness and safety profile in protecting children from JE virus infection....This study was designed to evaluate the surveillance sensitivity and changes over time of adverse event following immunization (AEFI) reports related to JEV-L based on the national AEFI surveillance system(NAEFISS) data before and after the introduction of vaccine administration law (LAW) from 2014 to2023...This study found a positive signal association between JEV-L immunization and fever in the pre- (1.394) and post-LAW period(2.833) and a signal for urticaria in the pre-LAW period (2.098).
Edwin J Asturias,Noel T Brewer,Oliver Brooks et al.
Edwin J Asturias et al.
Letter Regarding JPIDS-2024-021.R1: "New and Emerging Passive Immunization Strategies for Prevention of RSV During Infancy" [0.03%]
Ravi Jhaveri,Andrew S Handel
Ravi Jhaveri
Letter in Response to "New and Emerging Passive Immunization Strategies for Prevention of RSV During Infancy" by Joseph B. Domachowske, et al [0.03%]
Bradford D Gessner,Yasmeen Agosti,Jessica E Atwell et al.
Bradford D Gessner et al.
Serotype distribution of invasive and non-invasive pneumococcal disease in children ≤5 years of age following the introduction of 10- and 13-valent pneumococcal conjugate vaccines in infant national immunization programs: a systematic literature review [0.03%]
Patricia Izurieta,Mohammad AbdelGhany,Dorota Borys
Patricia Izurieta
Introduction: Widespread implementation of pneumococcal conjugate vaccines (PCVs)-namely the 7-valent PCV (PCV7), 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV), and 13-valent PCV (PCV13)-in infant national immunization programs has
Serotype distribution of invasive and non-invasive pneumococcal disease in adults ≥65 years of age following the introduction of 10- and 13-valent pneumococcal conjugate vaccines in infant national immunization programs: a systematic literature review [0.03%]
Patricia Izurieta,Dorota Borys
Patricia Izurieta
Introduction: Despite the widespread implementation of 10- and 13-valent pneumococcal conjugate vaccines (PCVs) in infant national immunization programs and anticipated herd effects, pneumococcal disease incidence remains relatively high among older adults....Conclusion: The persistence of certain PCV13-serotypes in pneumococcal disease among adults aged ≥65 years suggests that herd immunity by infant PCV immunization may be insufficient to provide optimal protection in this population.
Determinants of high vaccine confidence and uptake among the Australian public: insights from a cross-sectional study [0.03%]
Charles Travers Williams,Bandana Saini,Syed Tabish R Zaidi et al.
Charles Travers Williams et al.
Conclusion: Greater emphasis should be placed on raising awareness of trusted sources for vaccine information, and immunization programs should consider incorporating vaccine confidence tools to enhance communication strategies and encourage vaccine uptake.
O Y Oludoun,O Abiodun,B Gbadamosi et al.
O Y Oludoun et al.
The model integrates vertical and horizontal transmission pathways, treatment strategies, immunization efforts, and spontaneous clearance, providing a nuanced perspective compared to classical models.
Adverse Effects Following Covishield and Covaxin Vaccination in Pregnant and Non-pregnant Women: A Comparative Study From Ranchi, Jharkhand [0.03%]
Indrani Dutta,Atima Bharti
Indrani Dutta
Adverse events following immunization (AEFIs) were recorded and analyzed using SPSS version 24.0 (IBM Corp., Armonk, NY, USA). Results Vaccine acceptance was 54.6% among pregnant women and 45.39% among non-pregnant women.
Splenectomy following rituximab and cyclophosphamide for severe autoimmune hemolytic anemia in pregnancy [0.03%]
Tao Wang,Juan Yang,Bing Peng et al.
Tao Wang et al.
In the follow-up of 2 years, the underlying disease emerged as systemic lupus erythematosus, and the child grew up healthily with a routine immunization schedule....In the follow-up of 2 years, the underlying disease of AIHA emerged as systemic lupus erythematosus, and the child grew up healthily with a routine immunization schedule.
耗时 0.19776 秒，为您在
48229835
条记录里面共找到 10000 篇文章 [XML]